These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2419543)
21. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini. Sankaran H; Goldfine ID; Bailey A; Licko V; Williams JA Am J Physiol; 1982 Mar; 242(3):G250-7. PubMed ID: 6175228 [TBL] [Abstract][Full Text] [Related]
22. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists. Spanarkel M; Martinez J; Briet C; Jensen RT; Gardner JD J Biol Chem; 1983 Jun; 258(11):6746-9. PubMed ID: 6304053 [TBL] [Abstract][Full Text] [Related]
23. Distinct cholecystokinin receptors in brain and pancreas. Innis RB; Snyder SH Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6917-21. PubMed ID: 6256771 [TBL] [Abstract][Full Text] [Related]
24. Interaction of substance P with dispersed pancreatic acinar cells from the guinea pig. Relationships between structure, binding and biological activity. Sjödin L; Brodin E; Srivastava G Acta Physiol Scand; 1984 Jan; 120(1):21-6. PubMed ID: 6202096 [TBL] [Abstract][Full Text] [Related]
26. Decreased pancreatic CCK receptor binding and CCK-stimulated amylase release in Zucker obese rats. McLaughlin CL; Peikin SR; Baile CA Physiol Behav; 1984 Jun; 32(6):961-5. PubMed ID: 6208569 [TBL] [Abstract][Full Text] [Related]
27. Interaction of tryptophan-modified analogues of cholecystokinin-octapeptide with cholecystokinin receptors on pancreatic acini. Adachi H; Rajh HM; Tesser GI; de Pont JJ; Jensen RT; Gardner JD Biochim Biophys Acta; 1981 Dec; 678(3):358-63. PubMed ID: 6172157 [TBL] [Abstract][Full Text] [Related]
28. Direct modulation of pancreatic CCK receptors and enzyme secretion by insulin in isolated pancreatic acini from diabetic rats. Otsuki M; Williams JA Diabetes; 1983 Mar; 32(3):241-6. PubMed ID: 6186556 [TBL] [Abstract][Full Text] [Related]
29. Effect of a Rab3A effector domain-related peptide, CCK, and EGF in permeabilized pancreatic acini. Zeuzem S; Stryjek-Kaminska D; Caspary WF; Stein J; Piiper A Am J Physiol; 1994 Sep; 267(3 Pt 1):G350-6. PubMed ID: 7524341 [TBL] [Abstract][Full Text] [Related]
30. Maturation of cholecystokinin receptors in pancreatic acini of rats. Leung YK; Lee PC; Lebenthal E Am J Physiol; 1986 May; 250(5 Pt 1):G594-7. PubMed ID: 2422951 [TBL] [Abstract][Full Text] [Related]
31. Effect of estradiol on pancreatic amylase and cholecystokinin binding in ovariectomized guinea pigs. Guo YS; Singh P J Steroid Biochem; 1989 Sep; 33(3):459-64. PubMed ID: 2476588 [TBL] [Abstract][Full Text] [Related]
32. Irreversible inhibition by acetaldehyde of cholecystokinin-induced amylase secretion from isolated rat pancreatic acini. Sankaran H; Lewin MB; Wong A; Deveney CW; Wendland MF; Leimgruber RM; Geokas MC Biochem Pharmacol; 1985 Aug; 34(16):2859-63. PubMed ID: 2411269 [TBL] [Abstract][Full Text] [Related]
33. COOH-terminal fragments of cholecystokinin. A new class of cholecystokinin receptor antagonists. Jensen RT; Jones SW; Gardner JD Biochim Biophys Acta; 1983 May; 757(2):250-8. PubMed ID: 6189522 [TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin receptor occupation and cholecystokinin-induced calcium mobilization in the early phase in rat pancreatic acini. Kusui T; Sato S; Katsushima S; Honda T; Shigeno C; Konishi J Biochim Biophys Acta; 1991 Sep; 1094(2):231-7. PubMed ID: 1716460 [TBL] [Abstract][Full Text] [Related]
35. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors. von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882 [TBL] [Abstract][Full Text] [Related]
36. Functional cholecystokinin receptors are distinguished kinetically by biotinyl-Tyr-Gly-(Thr28,Nle31)CCK(25-33) in rat pancreatic acini. Winand J; Poloczek P; Delporte C; Moroder L; Svoboda M; Christophe J Biochim Biophys Acta; 1991 Oct; 1080(2):181-90. PubMed ID: 1718434 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin. Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546 [TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids increase cholecystokinin receptors and amylase secretion in pancreatic acinar AR42J cells. Logsdon CD J Biol Chem; 1986 Feb; 261(5):2096-101. PubMed ID: 2418020 [TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of a new cholecystokinin receptor probe that can be oxidatively radioiodinated. Pearson RK; Hadac EM; Miller LJ Gastroenterology; 1986 Jun; 90(6):1985-91. PubMed ID: 3009263 [TBL] [Abstract][Full Text] [Related]
40. Proglumide analogues: potent cholecystokinin receptor antagonists. Jensen RT; Murphy RB; Trampota M; Schneider LH; Jones SW; Howard JM; Gardner JD Am J Physiol; 1985 Aug; 249(2 Pt 1):G214-20. PubMed ID: 2411147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]